左旋布比卡因腰麻15例临床分析  

Clinical Analysis of 15 Cases of Levobupivacaine Spinal Anesthesia

在线阅读下载全文

作  者:印武[1] 陈丽红[1] 熊桂林[1] 鲁竟[1] 田孝军[1] 黄启文[1] 

机构地区:[1]荆州市第二人民医院麻醉科,湖北荆州434000

出  处:《药物流行病学杂志》2007年第4期205-206,209,共3页Chinese Journal of Pharmacoepidemiology

摘  要:目的:评价0.5%左旋布比卡因重比重液腰麻的安全性和临床效果。方法:ASAI~Ⅱ级妇产科择期手术患者30例,随机分为左旋布比卡因组(L组)和布比卡因组(B组)。入室开放静脉通道,输注平衡液10 ml/kg,30 min输完后,选择L_(3~4)间隙用笔尖式腰硬联合穿刺针,先行硬膜外穿刺,成功后,刺入配置好的腰麻针,见脑积液流出后,用5 ml OT针筒以0.1 ml·S^(-1)的速度注入配制好的药物(0.75%左旋布比卡因或0.75%布比卡因2 ml+10%葡萄糖1 ml),退出腰麻针,改平卧位。观察麻醉起效时间、维持时间、运动阻滞和恢复时间、麻醉效果以及血压、心率的变化和不良反应。结果:L组的起效时间(82.61±22.10)S,B组的起效时间(59.30±21.50)S;5 min内SBP、DBP、HR的变化明显轻于B组;维持时间、运动阻滞和恢复时间及麻醉效果差异不显著。结论:0.5%L-Bup重比重液腰麻后能取得与0.5%Bup重比重液同样的麻醉效果,循环更稳定。0.5%L-Bup重比重液作为腰麻用药是安全可行的。Objective: To evaluate the clinical safety and effectiveness of heavy specific gravity levobupivacaine in spinal block. Method: 30 selective general surgical patients of ASA Ⅰ~Ⅱ in obstetrics and gynecology were randomly divided into levobupivacaine group ( L group) and bupivacaine group ( B group). After opening the venous channel and transfusing equilibrium liquid 30 mins, the T 4 - 5 space was selected as the puncture site for the epidural puncture. The 2 medicaments were injected in the rate of 0.1 ml/s respectively. Then the anesthetizing onset time, maintenance time, time of motion blockade and restoration, effect of anesthesia, variations of blood pressure and heart rate and adverse drug reaction were observed. Result: The onset time was 82.61 ±22, 10 s in L group and 59.30 ±21,50s in B group, respectively. The variations of SBP, DBP and HR in L group were less than those in B group. There was no significant difference in the 2 groups in maintenance time, time of motion blockade and restoration and effect of anesthesia. Conclusion: Compared with bupivacaine, heavy specific gravity levobupivacaine can make the same anesthesia effect with a steadier blood circulation. The specific gravity levobupivacaine is a safe and feasible drug for spinal anesthesia.

关 键 词:左旋布比卡因 布比卡因 蛛网膜下腔阻滞 

分 类 号:R971.2[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象